Andrea Aramini Selected Research

befetupitant

9/2014

NK1 receptor antagonists as a new treatment for corneal neovascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Aramini Research Topics

Disease

6	Neuralgia (Stump Neuralgia) 12/2023 - 11/2014
4	Inflammation (Inflammations) 10/2023 - 08/2007
4	Pain (Aches) 07/2023 - 11/2014
4	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2019
3	Hyperalgesia 01/2022 - 11/2014
1	Kidney Diseases (Kidney Disease) 10/2023
1	Hyperglycemia 10/2023
1	Disease Progression 10/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023
1	Neuroinflammatory Diseases 07/2023
1	Chronic Pain 07/2023
1	Sarcopenia 01/2023
1	COVID-19 01/2023
1	Neoplasms (Cancer) 01/2023
1	Hearing Loss (Hearing Impairment) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Bone Diseases (Bone Disease) 01/2022
1	Hemorrhage 01/2022
1	Hyperplasia 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Atrophy 01/2021
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Facial Pain (Myofacial Pain) 01/2018
1	Postoperative Pain 01/2016
1	Corneal Neovascularization 09/2014
1	Corneal Perforation 09/2014
1	Burns 09/2014
1	Reperfusion Injury 08/2007

Drug/Important Bio-Agent (IBA)

3	Interleukin-8 (Interleukin 8)IBA 10/2023 - 08/2007
3	Complement C5a (Complement 5a)IBA 01/2023 - 01/2022
2	2'- ((4'- trifluoromethanesulfonyloxy)phenyl)- N- methanesulfonylpropionamideIBA 10/2023 - 01/2023
2	Alanine (L-Alanine)FDA Link 01/2023 - 01/2021
2	Branched-Chain Amino AcidsIBA 01/2023 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2021
2	AnaphylatoxinsIBA 01/2022 - 11/2014
2	DF2755AIBA 01/2022 - 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 10/2023
1	CytokinesIBA 10/2023
1	ketoprofen lysineIBA 07/2023
1	Gabapentin (Neurontin)FDA LinkGeneric 07/2023
1	Ketoprofen (Orudis)FDA LinkGeneric 07/2023
1	gamma-Aminobutyric Acid (GABA)IBA 07/2023
1	Therapeutic UsesIBA 07/2023
1	SaltsIBA 07/2023
1	Nerve Growth Factors (Neurotrophins)IBA 01/2023
1	Nerve Growth Factor (NGF)IBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	ChemokinesIBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	Complement System Proteins (Complement)IBA 04/2021
1	Complement C5 (Complement 5)IBA 04/2021
1	Isoleucine (L-Isoleucine)FDA Link 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	Valine (L-Valine)FDA Link 01/2021
1	Polymethyl Methacrylate (Sol)IBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Formaldehyde (Formol)FDA Link 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2016
1	CarrageenanIBA 01/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2014
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 09/2014
1	Substance PIBA 09/2014
1	befetupitantIBA 09/2014
1	AlkaliesIBA 09/2014
1	1- (N- (2- methoxybenzyl)acetylamino)- 3- (1H- indol- 3- yl)- 2- (N- (2- (4- (piperidin- 1- yl)piperidin- 1- yl)acetyl)amino)propane (Lanepitant)IBA 09/2014
1	TachykininsIBA 09/2014
1	reparixinIBA 08/2007

Therapy/Procedure

3	Therapeutics 01/2023 - 11/2014
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 12/2023
1	Intranasal Administration 01/2023
1	Immunotherapy 01/2023
1	Oral Administration 11/2014
1	Sutures (Suture) 09/2014
1	Topical Administration 09/2014
1	Organ Transplantation 08/2007